Bayer Consumer Care (Ex-North America Rights) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Bayer Consumer Care (Ex-North America Rights) General Information

Description

Rights to develop and commercialize ATX-101, a drug for facial fat reduction, outside the US and Canada. ATX-101 is a proprietary injectable formulation of a synthetic version of deoxycholic acid for the reduction of submental fat (double chin).

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Other Commercial Services
Primary Office
  • Peter Merian Strasse 84
  • Post Office Box
  • 4002 Basel
  • Switzerland
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bayer Consumer Care (Ex-North America Rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bayer Consumer Care (Ex-North America Rights)‘s full profile, request access.

Request a free trial

Bayer Consumer Care (Ex-North America Rights) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bayer Consumer Care (Ex-North America Rights)‘s full profile, request access.

Request a free trial